Pediatrix Medical Group (NYSE:MD) Shares Gap Down - Here's What Happened

Key Points

• Pediatrix shares gapped down, opening at $20.99 vs a prior close of $22.41 and last trading around $19.98, a roughly 11.0% decline on elevated volume.
• The company beat Q1 expectations with EPS of $0.44 versus $0.37 and revenue of $476.2M (up 3.9% year‑over‑year), yet the stock still sold off.
• Analysts hold a consensus rating of “Hold” with a $21.33 target and mixed recent actions (e.g., Deutsche Bank $19 target, UBS cut to $22, Truist raised to $23); institutional investors own about 97.7% of the shares.

Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $22.41, but opened at $20.99. Pediatrix Medical Group shares last traded at $19.9770, with a volume of 85,875 shares traded.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Zacks Research lowered Pediatrix Medical Group from a "strong-buy" rating to a "hold" rating in a report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft set a $19.00 target price on Pediatrix Medical Group in a report on Friday, February 20th. Weiss Ratings reissued a "hold (c+)" rating on shares of Pediatrix Medical Group in a report on Friday, March 27th. UBS Group reduced their target price on Pediatrix Medical Group from $23.00 to $22.00 and set a "neutral" rating on the stock in a report on Tuesday, February 24th. Finally, Truist Financial increased their target price on Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a "hold" rating in a report on Monday, April 13th. Two research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $21.33.

Pediatrix Medical Group Stock Down 11.0%

The firm has a 50 day moving average of $20.96 and a two-hundred day moving average of $21.21. The firm has a market capitalization of $1.66 billion, a price-to-earnings ratio of 10.28 and a beta of 0.70. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.66.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. The business had revenue of $476.20 million for the quarter, compared to analyst estimates of $465.83 million. Pediatrix Medical Group had a return on equity of 19.59% and a net margin of 8.64%.Pediatrix Medical Group's revenue was up 3.9% compared to the same quarter last year. During the same period last year, the firm posted $0.33 earnings per share. As a group, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 2.05 EPS for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Several large investors have recently bought and sold shares of the business. Keybank National Association OH boosted its stake in Pediatrix Medical Group by 2.0% in the first quarter. Keybank National Association OH now owns 22,941 shares of the company's stock valued at $491,000 after buying an additional 458 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Pediatrix Medical Group by 10.6% in the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company's stock valued at $101,000 after purchasing an additional 601 shares during the last quarter. PNC Financial Services Group Inc. raised its position in Pediatrix Medical Group by 4.5% in the third quarter. PNC Financial Services Group Inc. now owns 14,525 shares of the company's stock valued at $243,000 after purchasing an additional 631 shares during the last quarter. Gotham Asset Management LLC raised its position in Pediatrix Medical Group by 0.6% in the third quarter. Gotham Asset Management LLC now owns 116,093 shares of the company's stock valued at $1,945,000 after purchasing an additional 724 shares during the last quarter. Finally, ProShare Advisors LLC raised its position in Pediatrix Medical Group by 4.6% in the fourth quarter. ProShare Advisors LLC now owns 16,816 shares of the company's stock valued at $360,000 after purchasing an additional 734 shares during the last quarter. 97.71% of the stock is owned by institutional investors and hedge funds.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.